As the obesity epidemic continues rising, many physicians recognize the urgent need for specialized training beyond ...

As a pediatric obesity medicine specialist, I have witnessed first-hand the benefits of GLP-1 receptor agonists in the ...

Discover the growing demand for specialty training in obesity treatment as new options emerge. Learn about the current state and benefits of certification ...

Obesity is a major global health problem, increasing the risk of many serious diseases like heart disease, diabetes, and some ...

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...

As obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a role.

The KAER framework is designed to help primary care providers partner with older adults to engage in shared decision-making ...

Updated European guidelines for metabolic dysfunction–associated steatotic liver disease stressed a higher risk in people ...

Detailed price information for Bio-Path Holdings (BPTH-Q) from The Globe and Mail including charting and trades.

New CDC population data from 2023 show that in 23 states more than one in three adults (35%) has obesity. Before 2013, no state had an adult obesity prevalence at or above 35%. Currently, at least one ...

Raising awareness about breast cancer encourages women to be proactive about regular check-ups and healthy habits, which are ...